Table 1
Prevalence of exposures to indwelling devices on the day of the survey, overall and according to different ward specialties, Slovenian national healthcare-associated infection prevalence survey, 2017.
| Intensive care | General medicine | Surgery | Gynaecology, obstetrics & neonatology | Paediatrics | Other/mixed | All | (95% CI) | |
|---|---|---|---|---|---|---|---|---|
| Peripheral vascular catheter | 68.9% | 56.8% | 49.7% | 21.7% | 57.3% | 22.1% | 48.2% | (46.9% - 49.5%) |
| Central vascular catheter | 74.0% | 6.9% | 9.6% | 0.2% | 7.1% | 5.2% | 9.4% | (8.6% - 10.1%) |
| Urinary catheter | 81.1% | 20.9% | 18.5% | 6.8% | 1.1% | 13.7% | 19.1% | (18.1% - 20.2%) |
| Intubation | 48.0% | 1.0% | 2.3% | 0.6% | 2.1% | 1.3% | 3.1% | (2.7% - 3.6%) |
| Number of patients | 196 | 2190 | 1997 | 545 | 281 | 534 | 5743 | |
Table 2
Number and prevalence of different types of healthcare-associated infections (HAIs), overall and according to ward specialties, Slovenian national healthcare-associated infections prevalence survey, 2017.
| Intensive care | General medicine | Surgery | Gynaecology, obstetrics & neonatology | Paediatrics | Other | All | |
|---|---|---|---|---|---|---|---|
| Number | Number | Number | Number | ||||
| (prevalence) | (prevalence) | (prevalence) | (prevalence) | Number | Number | Number | |
| (prevalence) | (prevalence) | (prevalence) | |||||
| Pneumoniae | 35 (17.9%) | 38 (1.7%) | 19 (1.0%) | 1 (0.2%) | |||
| Surgical site infections | 5 ( 2.6%) | 4 (0.2%) | 65 (3.3%) | 3 (0.6%) | 3 (1.1%) | 11 (2.1%) | 107 (1.9%) |
| Urinary tract infections | 6 ( 3.1%) | 41 (1.9%) | 15 (0.8%) | 1 (0.2%) | 0 (0.0%) | 7 (1.3%) | 84 (1.5%) |
| Systemic infections | 3 ( 1.5%) | 22 (1.0%) | 13 (0.7%) | 0 (0.0%) | 1 (0.4%) | 5 (0.9%) | 69 (1.2%) |
| Gastro-intestinal system infections | 2 ( 1.0%) | 13 (0.6%) | 4 (0.2%) | 0 (0.0%) | 0 (0.0%) | 2 (0.4%) | 40 (0.7%) |
| Bloodstream infections with CRI3 | 6 ( 3.1%) | 10 (0.5%) | 3 (0.2%) | 0 (0.0%) | 0 (0.0%) | 5 (0.9%) | 24 (0.4%) |
| Skin and soft tissue infections | 0 ( 0.0%) | 4 (0.2%) | 4 (0.2%) | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | 20 (0.3%) |
| Central nervous system infections | 1 ( 0.5%) | 3 (0.1%) | 3 (0.2%) | 0 (0.0%) | 0 (0.0%) | 2 (0.4%) | 10 (0.2%) |
| Eye, Ear, Nose or Mouth infection | 0 ( 0.0%) | 5 (0.2%) | 1 (0.1%) | 1 (0.2%) | 1 (0.4%) | 0 (0.0%) | 8 (0.1%) |
| Other lower respiratory tract infections | 4 ( 2.0%) | 3 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) | 8 (0.1%) |
| Bone and joint infections | 0 ( 0.0%) | 0 (0.0%) | 5 (0.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 7 (0.1%) |
| Cardiovascular system infections | 0 ( 0.0%) | 1 (0.0%) | 4 (0.2%) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) | 6 (0.1%) |
| Catheter-related infections w/o BSIs | 0 ( 0.0%) | 2 (0.1%) | 1 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 5 (0.1%) |
| Reproductive tract infections | 0 ( 0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (0.4%) | 0 (0.0%) | 0 (0.0%) | 3 (0.1%) |
| Specific neonatal infections | 4 ( 2.0%) | 0 (0.0%) | 0 (0.0%) | 8 (1.5%) | 0 (0.0%) | 0 (0.0%) | 2 (0.0%) |
| Patients with at least one HAIa | 60 (30.6%) | 127 (5.8%) | 134 (6.7%) | 16 (2.9%) | 4 (1.4%) | 0 (0.0%) | 16 (0.3%) |
| 9 (3.2%) | 31 (5.8%) | 377 (6.6%) | |||||
[i] CRI3: catheter-related bloodstream infection with microbiological documentation of the relationship between the vascular catheter and the bloodstream infection.
[ii] w/o BSIs: without bloodstream infections.
[iii] a Patients can have several HAIs, thus the numbers in columns do not necessarily add up to the number of patients with at least one HAI.
Table 3
Microorganisms identified in healthcare-associated infections (HAIs) overall and by most common types of HAIs, Slovenian national healthcare-associated infections prevalence survey, 2017.
| Pneumonia/lower respiratory tract infections | Surgical site infections | Urinary tract infections | Bloodstream infections | Gastrointestinal tract infections | All HAIs | |
|---|---|---|---|---|---|---|
| Number | Number | Number | Number | Number | Number | |
| Number of all HAIs | 116 | 84 | 69 | 33 | 25 | 409 |
| Number of HAIs with microorganisms all | 50 | 44 | 50 | 25 | 19 | 214 |
| Number of microorganisms | 83 | 73 | 60 | 27 | 23 | 301 |
| Gram-positive cocci Staphylococcus aureus | 16 9 | 34 9 | 10 0 | 13 4 | 30 | 94 30 |
| Streptococcus spp. | 4 | 12 | 7 | 3 | 2 | 30 |
| Coagulase-negative staphylococci | 1 | 9 | 3 | 5 | 0 | 23 |
| Other gram-positive cocci | 2 | 4 | 0 | 1 | 1 | 11 |
| Gram-negative cocci | 0 | 0 | 0 | 0 | 0 | 0 |
| Enterobacteriaceae | 38 | 20 | 39 | 11 | 6 | 123 |
| Escherichia coli | 5 | 6 | 19 | 7 | 2 | 40 |
| Enterobacter spp. | 10 | 7 | 4 | 2 | 1 | 28 |
| Klebsiella spp. | 11 | 2 | 7 | 1 | 1 | 24 |
| Proteus spp. | 3 | 3 | 5 | 0 | 1 | 13 |
| Other Enterobacteriaceae | 9 | 2 | 4 | 1 | 1 | 18 |
| Non-fermenting gram-negative bacteria | 18 | 6 | 7 | 0 | 1 | 33 |
| Pseudomonas aeruginosa | 9 | 4 | 6 | 0 | 1 | 21 |
| Other non-Enterobacteriaceae | 9 | 2 | 1 | 0 | 0 | 12 |
| Anaerobic bacilli | 0 | 8 | 0 | 1 | 12 | 22 |
| Clostridium difficile | 0 | 0 | 0 | 0 | 12 | 12 |
| Other anaerobes | 0 | 8 | 0 | 1 | 0 | 10 |
| Other bacteria | 0 | 0 | 0 | 0 | 0 | 0 |
| Fungi | 11 | 5 | 4 | 2 | 0 | 27 |
| Candida spp. | 9 | 5 | 4 | 2 | 0 | 25 |
| Other fungi | 2 | 0 | 0 | 0 | 0 | 2 |
| Virus | 0 | 0 | 0 | 0 | 1 | 2 |
| Negative codes | 62 | 40 | 19 | 7 | 6 | 189 |
| Examination not done | 37 | 24 | 6 | 0 | 2 | 87 |
| Not yet available/missing | 11 | 11 | 9 | 6 | 2 | 51 |
| Sterile examination | 13 | 5 | 3 | 1 | 1 | 48 |
| Microorganism not identified | 1 | 0 | 1 | 0 | 1 | 3 |
Table 4
Prevalence of healthcare-associated infections (HAIs) acquired during current hospitalisation according to patients’ characteristics, ward specialties, and exposure to extrinsic risks and results of univariate and multivariate analysis of association, Slovenian national healthcare-associated infections prevalence survey, 2017.
| Univariate analyses (whole data) | Univariate analyses (restricted data) | Multivariate analyses (restricted data) | ||||||
|---|---|---|---|---|---|---|---|---|
| Prevalence of HAIs | Number of patients (base) | Odds ratio | p-value (95% CI) | Odds ratio | p-value (95% CI) | Adjusted odds ratio | p-value (95% CI) | |
| Age | ||||||||
| <50 years | 3.9% | 1588 | 1 | p<0.001 | 1 | p<0.001 | ||
| 50–79 years | 7.7% | 3017 | 2.1 | (1.5-2.7) | 2.0 | (1.5-2.7) | ||
| ≥80 years | 7.3% | 1138 | 1.9 | (1.4-2.7) | 1.9 | (1.4-2.7) | ||
| McCabe index | ||||||||
| Non-fatal disease | 4.7% | 4143 | 1 | p<0.001 | 1 | p<0.001 | ||
| Ultimately fatal disease | 10.3% | 1128 | 2.3 | (1.8-2.9) | 2.3 | (1.8-2.9) | ||
| Rapidly fatal disease | 14.5% | 394 | 3.4 | (2.5-4.7) | 3.3 | (2.4-4.6) | ||
| Surgery (during current hospitalisation) | ||||||||
| No | 4.9% | 3904 | 1 | p<0.001 | 1 | p<0.001 | 1 | p<0.01 |
| Yes | 10.2% | 1827 | 2.2 | (1.8-2.7) | 2.2 | (1.8-2.7) | 1.6 | (1.2-2.0) |
| Intubation | ||||||||
| No | 5.8% | 5565 | 1 | p<0.001 | 1 | p<0.001 | ||
| Yes | 30.3% | 178 | 7.1 | (5.0-9.9) | 7.1 | (5.0-9.9) | ||
| Central vascular catheter | ||||||||
| No | 4.7% | 5202 | 1 | p<0.001 | 1 | p<0.001 | 1 | p<0.001 |
| Yes | 24.8% | 537 | 6.7 | (5.3-8.5) | 6.7 | (5.3-8.5) | 4.1 | (3.1-5.4) |
| Peripheral vascular catheter | ||||||||
| No | 4.6% | 2967 | 1 | p<0.001 | 1 | p<0.001 | 1 | p<0.001 |
| Yes | 8.7% | 2769 | 2.0 | (1.6-2.5) | 2.0 | (1.6-2.5) | 3.0 | (2.3-3.9) |
| Urinary catheter | ||||||||
| No | 4.1% | 4640 | 1 | p<0.001 | 1 | p<0.001 | 1 | p<0.001 |
| Yes | 16.8% | 1099 | 4.7 | (3.8-5.8) | 4.7 | (3.8-5.8) | 1.8 | (1.4-2.3) |
| Length of hospital staya: | ||||||||
| ≤3 days | 1.1% | 1892 | 1 | p<0.001 | 1 | p<0.001 | 1 | p<0.001 |
| 4-7 days | 3.1% | 1434 | 2.8 | (1.7-4.8) | 2.8 | (1.7-4.8) | 2.6 | (1.5-4.4) |
| 8-14 days | 9.5% | 1153 | 9.3 | (5.8-14.9) | 9.3 | (5.8-14.9) | 9.4 | (5.8-15.2) |
| ≥15 days | 16.1% | 1264 | 17.0 | (10.8-26.9) | 16.9 | (10.7-26.7) | 15.5 | (9.7-24.8) |
[i] 5,719 individuals with information on all risk factors included in the final multivariate model were included in multivariate analyses on the restricted data (99.6% of all individuals surveyed).
[ii] a Length of hospital stay was computed until the day of the survey for patients without HAIs and for those with HAIs until the day of occurrence of HAIs (first HAI, if several).
